Viridian Therapeutics closes 2020 with $127.6M in cash
BOULDER — Viridian Therapeutics Inc. (Nasdaq: VRDN) said it has the cash to keep it afloat through late 2023 after […]
Source: BizWest
Check out market updates
BOULDER — Viridian Therapeutics Inc. (Nasdaq: VRDN) said it has the cash to keep it afloat through late 2023 after […]
Source: BizWest